These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 26586047)

  • 1. Is there a genetic predisposition to new-onset diabetes after kidney transplantation?
    Reddy YN; Abraham G; Sundaram V; Reddy PP; Mathew M; Nagarajan P; Mehra N; Ramachandran A; Ali AA; Reddy YN
    Saudi J Kidney Dis Transpl; 2015 Nov; 26(6):1113-20. PubMed ID: 26586047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conversion from tacrolimus to cyclosporine in patients with new-onset diabetes after renal transplant: an open-label randomized prospective pilot study.
    Rathi M; Rajkumar V; Rao N; Sharma A; Kumar S; Ramachandran R; Kumar V; Kohli HS; Gupta KL; Sakhuja V
    Transplant Proc; 2015 May; 47(4):1158-61. PubMed ID: 26036543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The combined effect of pre-transplant triglyceride levels and the type of calcineurin inhibitor in predicting the risk of new onset diabetes after renal transplantation.
    Porrini E; Delgado P; Alvarez A; Cobo M; Pérez L; González-Posada JM; Hortal L; Gallego R; García JJ; Checa M; Morales A; Salido E; Hernández D; Torres A
    Nephrol Dial Transplant; 2008 Apr; 23(4):1436-41. PubMed ID: 18029372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and genetic risk factors for new-onset diabetes mellitus after transplantation (NODAT) in major transplant centres in Malaysia.
    Guad RM; Taylor-Robinson AW; Wu YS; Gan SH; Zaharan NL; Basu RC; Liew CSL; Wan Md Adnan WAH
    BMC Nephrol; 2020 Sep; 21(1):388. PubMed ID: 32894076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of type of calcineurin inhibitor on post-transplant tuberculosis: Single-center study from India.
    Agarwal SK; Bhowmik D; Mahajan S; Bagchi S
    Transpl Infect Dis; 2017 Feb; 19(1):. PubMed ID: 27775825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Side effects of the calcineurin inhibitor, such as new-onset diabetes after kidney transplantation.
    Borda B; Lengyel C; Várkonyi T; Kemény E; Ottlakán A; Kubik A; Keresztes C; Lázár G
    Acta Physiol Hung; 2014 Sep; 101(3):388-94. PubMed ID: 25183511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tacrolimus and angiotensin receptor blockers associated with changes in serum adiponectin level in new-onset diabetes after renal transplantation: single-center cross-sectional analysis.
    Nishimura K; Kishikawa H; Kato T; Kobayashi Y; Fujii N; Takahara S; Ichikawa Y
    Transpl Int; 2009 Jul; 22(7):694-701. PubMed ID: 19254242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New-onset diabetes after kidney transplantation: can the risk be modified by choosing immunosuppression regimen based on pretransplant viral serology?
    Santos AH; Chen C; Casey MJ; Womer KL; Wen X
    Nephrol Dial Transplant; 2018 Jan; 33(1):177-184. PubMed ID: 29045704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multivariable risk of developing new onset diabetes after transplant-results from a single-center study of 481 adult, primary kidney transplant recipients.
    Gaynor JJ; Ciancio G; Guerra G; Sageshima J; Hanson L; Roth D; Goldstein MJ; Chen L; Kupin W; Mattiazzi A; Tueros L; Flores S; Barba LJ; Lopez A; Rivas J; Ruiz P; Vianna R; Burke GW
    Clin Transplant; 2015 Apr; 29(4):301-10. PubMed ID: 25581205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pre-transplantation glucose testing for predicting new-onset diabetes mellitus after renal transplantation.
    Ramesh Prasad GV; Huang M; Bandukwala F; Nash MM; Rapi L; Montada-Atin T; Meliton G; Zaltzman JS
    Clin Nephrol; 2009 Feb; 71(2):140-6. PubMed ID: 19203506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New-onset diabetes mellitus in kidney transplant recipients discharged on steroid-free immunosuppression.
    Luan FL; Steffick DE; Ojo AO
    Transplantation; 2011 Feb; 91(3):334-41. PubMed ID: 21242885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single-nucleotide polymorphisms in P450 oxidoreductase and peroxisome proliferator-activated receptor-α are associated with the development of new-onset diabetes after transplantation in kidney transplant recipients treated with tacrolimus.
    Elens L; Sombogaard F; Hesselink DA; van Schaik RH; van Gelder T
    Pharmacogenet Genomics; 2013 Dec; 23(12):649-57. PubMed ID: 24113216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical outcome in heart transplant recipients receiving everolimus in combination with dosage reduction of the calcineurin inhibitor cyclosporine A or tacrolimus.
    Fuchs U; Zittermann A; Ensminger SM; Schulz U; Gummert JF
    Transpl Immunol; 2014 Aug; 31(2):87-91. PubMed ID: 24932812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of insulin resistance indices in predicting new-onset diabetes after kidney transplantation.
    Nagaraja P; Ravindran V; Morris-Stiff G; Baboolal K
    Transpl Int; 2013 Mar; 26(3):273-80. PubMed ID: 23230898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New-Onset Diabetes After Kidney Transplantation and Pretransplant Hypomagnesemia.
    Sinangil A; Celik V; Barlas S; Sakaci T; Koc Y; Basturk T; Akin EB; Ecder T
    Prog Transplant; 2016 Mar; 26(1):55-61. PubMed ID: 27136250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of oral glucose tolerance tests to risk stratify for new-onset diabetes after transplantation: An underdiagnosed phenomenon.
    Sharif A; Moore RH; Baboolal K
    Transplantation; 2006 Dec; 82(12):1667-72. PubMed ID: 17198257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of new onset diabetes after renal transplantation.
    Joss N; Staatz CE; Thomson AH; Jardine AG
    Clin Transplant; 2007; 21(1):136-43. PubMed ID: 17302602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tacrolimus decreases insulin sensitivity without reducing fasting insulin concentration: a 2-year follow-up study in kidney transplant recipients.
    Chen QJ; Li J; Zuo SR; Zhang YP; Jia SJ; Yuan H; Liu SK; Cheng K; Ming YZ; Zuo XC; Luo AJ; Xie WZ; Cai JJ; Yang M; Wang JL
    Ren Fail; 2015 May; 37(4):601-6. PubMed ID: 25644968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early prediction of new-onset diabetes mellitus by fifth-day fasting plasma glucose, pulse pressure, and proteinuria.
    Rodrigo E; Santos L; Piñera C; Quintanar JA; Ruiz JC; Fernández-Fresnedo G; Palomar R; Gómez-Alamillo C; Arias M
    Transplant Proc; 2011; 43(6):2208-10. PubMed ID: 21839235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic polymorphisms of the transcription factor NFATc4 and development of new-onset diabetes after transplantation in Hispanic kidney transplant recipients.
    Chen Y; Sampaio MS; Yang JW; Min D; Hutchinson IV
    Transplantation; 2012 Feb; 93(3):325-30. PubMed ID: 22234350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.